Recent Updates
Recently added Catalysts
PAHC Positive Sentiment

Phibro Animal Health Corporation Declares Quarterly Dividend

Tuesday, July 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Phibro Animal Health Corporation's Board of Directors has announced a quarterly cash dividend of $0.12 per share for both Class A and Class B common stock. This dividend is set to be paid on September 23, 2026, to shareholders on record as of September 2, 2026. The announcement highlights the company's ongoing commitment to shareholder returns.
Price reaction · baseline $36.37 (2026-07-28 close) · hit after-hours · clean, no other PAHC news in the window
day 0 close · peak
+1.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Quarterly dividend declared at $0.12 per share.
  • Demonstrates commitment to returning value to shareholders.
  • Reflects financial stability of Phibro Animal Health Corporation.

Full Press Release Details

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, , payable on September 23, 2026, to stockholders of record at the close of business on September 2, 2026.About Phibro Animal Health CorporationPhibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner w

Frequently Asked Questions

What is the declared dividend amount by Phibro Animal Health?

Phibro Animal Health declared a quarterly cash dividend of $0.12 per share.

When will the dividend be paid to shareholders?

The dividend will be paid on September 23, 2026.

Who is eligible for the dividend payment?

Shareholders of record as of September 2, 2026, are eligible.

What types of stock are included in the dividend?

The dividend applies to both Class A and Class B common stock.

ShareAdd on Google
Tags: PAHC Phibro Animal Health dividend animal health quarterly dividend
Last updated: Jul 28, 2026

Biotech snapshot

Cash runway
$82M liquidity · $0M/mo burn
Low dilution risk